The 2003 ASBMB-Avanti Award in Lipids Address: Applications of novel synthetic lipids to biological problems

Chemistry and Physics of Lipids

Volumn 129, Issue 2, 2004, Pages 111-131

  Bittman, Robert ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Alphavirus; Antitumor lipid; Ceramide; Cytolysin; Glycosphingolipids; Lysophosphospholipids

Indexed keywords

AMINO ACID DERIVATIVE; ANTINEOPLASTIC AGENT; CERAMIDE DERIVATIVE; CEREBROSIDE; CHOLESTEROL; CHOLINE DERIVATIVE; CYTOLYSIN; GLYCOSPHINGOLIPID; LIPID; LYSOPHOSPHATIDIC ACID; N OCTANOYLCERAMIDE; PROTEIN DERIVATIVE; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ACADEMIC ACHIEVEMENT; BINDING AFFINITY; BIOCHEMISTRY; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CAVEOLA; CIS ISOMER; CORRELATION ANALYSIS; CYTOLYSIS; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TARGETING; ENANTIOMER; ENDOCYTOSIS; EXPERIMENTAL TEST; FLUORESCENCE MICROSCOPY; HUMAN; LIPID BILAYER; LIPOGENESIS; MAMMAL CELL; MEMBRANE PERMEABILITY; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; REVIEW; SEMLIKI FOREST ALPHAVIRUS; SIGNAL TRANSDUCTION; SINDBIS VIRUS; STRUCTURE ANALYSIS; TRANS ISOMER; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; AWARDS AND PRIZES; BIOCHEMISTRY; CERAMIDES; CHOLESTEROL; GLYCOSPHINGOLIPIDS; HUMANS; LIPIDS; MEMBRANE MICRODOMAINS; SPHINGOMYELINS;

ALPHAVIRUS; MAMMALIA;

EID: 1842814985     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2004.01.004     Document Type: Review

References (67)

1. Ahn A., Gibbons D.L., Kielian M. The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J. Virol. 76:2002;3267-3275.
2. Arthur G., Bittman R. The inhibition of cell signaling pathways by antitumor ether lipids. Biochim. Biophys. Acta. 1390:1998;85-102.
3. Bavari S., Bosio C.M., Wiegand E., Ruthel G., Will A.B., Geisbert T.W., Hevey M., Schmaljohn C., Schmaljohn A., Aman M.J. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195:2002;593-602.
4. Bielawska A., Crane H.M., Liotta D., Obeid L.M., Hannun Y.A. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J. Biol. Chem. 268:1993;26226-26232.
5. Bittman R., Byun H.-S., Mercier B., Salari H. Isosteric phosphonate analogs of ET-16-OMe. Synthesis and biological evaluation of the enantiomers of 2′-(trimethylammonio)ethyl 4-(hexadecyloxy)-3-methoxybutanephosphonate and 2′-(trimethylammonio)ethyl 4-(hexadecylthio)-3-methoxybutanephosphonate. J. Med. Chem. 37:1994;425-430.
6. Bittman R., Swords B., Liliom K., Tigyi G. Inhibitors of lipid phosphatidate receptors: N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids. J. Lipid Res. 37:1996;391-398.
7. Brunner J. Photochemical labeling of apolar phase of membranes. Methods Enzymol. 172:1989;628-687.
8. Choudhury A., Dominguez M., Puri V., Sharma D.K., Narita K., Wheatley C.L., Marks D.L., Pagano R.E. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 109:2002;1541-1550.
9. Chun J., He L., Byun H.-S., Bittman R. Synthesis of ceramide analogues having the C(4)-C(5) bond of the long-chain base as part of an aromatic or heteroaromatic system. J. Org. Chem. 65:2000;7634-7640.
10. 6 ceramides. J. Org. Chem. 67:2002;2600-2605.
11. Chun J., Byun H.-S., Arthur G., Bittman R. Synthesis and growth inhibitory activity of chiral 5-hydroxy-2-N-acyl-(3E)-sphingenines: ceramides with an unusual sphingoid backbone. J. Org. Chem. 68:2003a;355-359.
12. Chun J., Byun H.-S., Bittman R. First asymmetric synthesis of 6-hydroxy-4-sphingenine-containing ceramides. Use of chiral propargylic alcohols to prepare a lipid found in human skin. J. Org. Chem. 68:2003b;348-354.
13. Dormán G., Prestwich G.D. Benzophenone photoprobes in biochemistry. Biochemistry. 33:1994;5661-5673.
14. Epand R.M. Cholesterol in bilayers of sphingomyelin or dihydrosphingomyelin at concentrations found in ocular lens membranes. Biophys. J. 84:2003;3102-3110.
15. Füller, M., Wang, de A., Tigyi, G., Siess, W., 2003. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate. Cell Signal. 15, 367-375.
16. Fujiwara Y., Sebok A., Meakin S., Kobayashi T., Murakami-Murofushi K., Tigyi G. Cyclic phosphatidic acid elicits neurotrophin-like actions in embryonic hippocampal neurons. J. Neurochem. 87:2003;1272-1283.
17. 3 (edelfosine), a proapoptotic agent in tumor cells. Curr. Drug Metab. 3:2002;491-525.
18. Gueguen G., Gaige B., Grevy J.-M., Rogalle P., Bellan J., Wilson M., Klaebe A., Pont F., Simon M.-F., Chap H. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry. 38:1999;8440-8450.
19. He L., Byun H.-S., Bittman R. Stereoselective preparation of ceramide and its skeleton backbone modified analogues via cyclic thionocarbonate intermediates derived by catalytic asymmetric dihydroxylation of α,β-unsaturated ester precursors. J. Org. Chem. 65:2000;7627-7633.
20. Heise C.E., Santos W.L., Schreihofer A.M., Heasley B.H., Mukhin Y.V., Macdonald T.L., Lynch K.R. Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist. Mol. Pharmacol. 60:2001;1173-1180.
21. Hla T. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol. Res. 47:2003;401-407.
22. Huang J., Feigenson G.W. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys. J. 76:1999;2142-2157.
23. Jarvis W.D., Grant S. The role of ceramide in the cellular response to cytotoxic agents. Curr. Opin. Oncol. 10:1998;552-559.
24. Karasavvas N., Erukulla R.K., Bittman R., Lockshin R., Zakeri Z. Stereospecific induction of apoptosis in U937 cells by N-octanoylsphingosine stereoisomers and N-octylsphingosine. The ceramide amide group is not required for apoptosis. Eur. J. Biochem. 236:1996;729-737.
25. Kielian M., Klimjack M.R., Ghosh S., Duffus W.A. Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus. J. Cell Biol. 134:1996;863-872.
26. Kolesnick R.N., Kronke M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60:1998;643-665.
27. Kwon H.C., Lee K.C., Cho O.R., Jung I.Y., Cho S.Y., Kim S.Y., Lee K.R. Sphingolipids from Bombycis corpus 101A and their neurotrophic effects. J. Nat. Prod. 66:2003;466-469.
28. Liliom K., Bittman R., Swords B., Tigyi G. N-Palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors. Mol. Pharmacol. 50:1996;616-623.
29. Lohmeyer M., Bittman R. Antitumor ether lipids and alkylphosphocholines. Drugs Fut. 19:1994;1021-1037.
30. Lohmeyer M., Workman P. Lack of enantioselectivity in the in vitro antitumor cytotoxicity and membrane - damaging activity of ether lipid SRI 62-834: further evidence for a nonreceptor-mediated mechanism of action. Biochem. Pharmacol. 44:1992;819-823.
31. Lu X., Cseh S., Byun H.-S., Tigyi G., Bittman R. Total synthesis of two photoactivatable analogues of the growth-factor-like mediator sphingosine 1-phosphate: differential interaction with protein targets. J. Org. Chem. 68:2003;7046-7050.
32. Mattjus P., Malewicz B., Valiyaveettil J.T., Baumann W.J., Bittman R., Brown R.E. Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranes. J. Biol. Chem. 277:2002;19476-19481.
33. McIntyre T.M., Pontsler A.V., Silva A.R., St. Hilaire A., Xu Y., Hinshaw J.C., Zimmerman G.A., Hama K., Aoki J., Arai H., Prestwich G.D. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist. Proc. Natl. Acad. Sci. U.S.A. 100:2003;131-136.
34. Meuillet E.J., Mahadevan D., Vankayalapati H., Berggren M., Williams R., Coon A., Kozikowski A.P., Powis G. Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues. Mol. Cancer Ther. 2:2003;389-399.
35. Moesby L., Corver J., Erukulla R.K., Bittman R., Wilschut J. Sphingolipids activate membrane fusion of Semliki Forest virus in a stereospecific manner. Biochemistry. 34:1995;10319-10324.
36. L. Cancer Res. 57:1997;1320-1328.
37. Ogretman B., Hannun Y.A. Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance. Drug Resist. Update. 4:2001;368-377.
38. Pagano R.E., Watanabe R., Wheatley C., Dominguez M. Applications of BODIPY-sphingolipid analogs to study lipid traffic and metabolism in cells. Methods Enzymol. 312:2000;523-534.
39. Pettus B.J., Chalfant C.E., Hannun Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta. 1585:2002;114-125.
40. 3 receptor-selective agonist activity. J. Med. Chem. 46:2003;5575-5578.
41. Radin N.S. Designing anticancer drugs via the Achilles heel: ceramide, allylic ketones, and mitochondria. Bioorg. Med. Chem. 11:2003;2123-2142.
42. Raloff J. Sphinx of fat. Sci. News. 151:1997;342-343.
43. Rother E., Brandl R., Baker D.L., Goyal P., Gebhard H., Tigyi G., Siess W. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation. 108:2003;741-747.
44. Ruiter G.A., Zerp S.F., Bartelink H., van Blitterswijk W.J., Verheij M. Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs. 14:2003;167-173.
45. Ruvolo P.P. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res. 47:2003;383-392.
46. 3) inhibits the association between Ras and Raf-1. Anticancer Res. 23:2003;2291-2305.
47. 2-terminal protein kinase in neuronal tumor cells. J. Med. Chem. (vol. 47, in press).
48. Singh R.D., Puri V., Valiyaveettil J.T., Marks D.L., Bittman R., Pagano R.E. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol. Biol. Cell. 14:2003;3254-3265.
49. Smit J.M., Bittman R., Wilschut J. Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J. Virol. 73:1999;8476-8484.
50. Smit J.M., Li G., Schoen P., Corver J., Bittman R., Lin K.C., Wilschut J. Fusion of alphaviruses with liposomes is a non-leaky process. FEBS Lett. 521:2002;62-66.
51. Smit J., Waarts B.-L., Bittman R., Wilschut J. Liposomes as target membranes in the study of virus-receptor interaction and membrane fusion. Methods Enzymol. 372:2003;374-392.
52. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat. Rev. Mol. Cell. Biol. 4:2003a;397-407.
53. Spiegel S., Milstien S. Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochem. Soc. Trans. 31:2003b;1216-1219.
54. 2H NMR study Biophys. J. 85:2003;1013-1024.
55. Strauss J.H., Strauss E.G. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:1994;491-562.
56. Struckhoff, A.P., Bittman, R., Burow, M.E., Clejan, S., Elliot, S., Hammond, T., Tang, Y., Beckman, B.S., 2004. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. J. Pharmacol. Exp. Ther. (in press).
57. Tigyi G., Parrill A.L. Molecular mechanisms of lysophosphatidic acid action. Prog. Lipid Res. 42:2003;498-526.
58. Tokumura A., Sinomiya J., Kishimoto S., Tanaka T., Kogure K., Sugiura T., Satouchi K., Waku K., Fukuzawa K. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem. J. 365:2002;617-628.
59. Triantafilou K., Triantafilou M. Lipid raft microdomains: key sites for Coxsackievirus A9 infectious cycle. Virology. 317:2003;128-135.
60. Waarts B.-L., Bittman R., Wilschut J. Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes. J. Biol. Chem. 277:2002;38141-38147.
61. Wilschut J., Corver J., Nieva J.L., Bron R., Moesby L., Reddy K.C., Bittman R. Fusion of Semliki Forest virus with cholesterol-containing liposomes at low pH: a specific requirement for sphingolipids. Mol. Membr. Biol. 12:1995;143-149.
62. 1. J. Biol. Chem. 279, 6595-6605.
63. Yokoyama K., Baker D.L., Virag T., Liliom K., Byun H.-S., Tigyi G., Bittman R. Stereochemical properties of lysophosphatidic acid receptor activation and metabolism. Biochim. Biophys. Acta. 1582:2002;295-308.
64. Zhang, C., Baker, D.L., Yasuda, S., Makarova, N., Balazs, L., Johnson, L.R., Marathe, G.K., McIntyre, T.M., Xu, Y., Prestwich, G.D., Byun, H.-S., Bittman, R., Tigyi, R., 2004. Lysophosphatidic acid induces neointima formation through PPARγ activation. J. Exp. Med. (vol. 199, in press).
65. Zitzer A., Palmer M., Weller U., Wassenaar T., Biermann C., Tranum-Jensen J., Bhakdi S. Mode of primary binding to target membranes and pore formation induced by Vibrio cholerae cytolysin (hemolysin). Eur. J. Biochem. 247:1997;209-216.
66. Zitzer A., Zitzer O., Bhakdi S., Palmer M. Oligomerization of Vibrio cholerae cytolysin yields a pentameric pore and has a dual specificity for cholesterol and sphingolipids in the target membrane. J. Biol. Chem. 274:1999;1375-1380.
67. Zitzer A., Bittman R., Verbicky C.A., Erukulla R.K., Bhakdi S., Weis S., Valeva A., Palmer M. Coupling of cholesterol and cone-shaped lipids in bilayers augments membrane permeabilization by the cholesterol-specific toxins streptolysin O and Vibrio cholerae cytolysin. J. Biol. Chem. 276:2001;14628-14633.